Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.

<h4>Background</h4>There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah V Kedenge, Beth P Kangwana, Evelyn W Waweru, Andrew J Nyandigisi, Jayesh Pandit, Simon J Brooker, Robert W Snow, Catherine A Goodman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054371&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726032448323584
author Sarah V Kedenge
Beth P Kangwana
Evelyn W Waweru
Andrew J Nyandigisi
Jayesh Pandit
Simon J Brooker
Robert W Snow
Catherine A Goodman
author_facet Sarah V Kedenge
Beth P Kangwana
Evelyn W Waweru
Andrew J Nyandigisi
Jayesh Pandit
Simon J Brooker
Robert W Snow
Catherine A Goodman
author_sort Sarah V Kedenge
collection DOAJ
description <h4>Background</h4>There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in Kenya, comprising provision of subsidized packs of paediatric ACT to retail outlets, training of retail staff, and community awareness activities. The results demonstrated a substantial increase in ACT availability and coverage, though patient counselling and adherence were suboptimal. We conducted a qualitative study in order to understand why these successes and limitations occurred.<h4>Methodology/principal findings</h4>Eighteen focus group discussions were conducted, 9 with retailers and 9 with caregivers, to document experiences with the intervention. Respondents were positive about intervention components, praising the focused retailer training, affordable pricing, strong promotional activities, dispensing job aids, and consumer friendly packaging, which are likely to have contributed to the positive access and coverage outcomes observed. However, many retailers still did not stock ACT, due to insufficient supplies, lack of capital and staff turnover. Advice to caregivers was poor due to insufficient time, and poor recall of instructions. Adherence by caregivers to dosing guidelines was sub-optimal, because of a wish to save tablets for other episodes, doses being required at night, stopping treatment when the child felt better, and the number and bitter taste of the tablets. Caregivers used a number of strategies to obtain paediatric ACT for older age groups.<h4>Conclusions/significance</h4>This study has highlighted that important components of a successful ACT subsidy intervention are regular retailer training, affordable pricing, a reliable supply chain and community mobilization emphasizing patient adherence and when to seek further care.
format Article
id doaj-art-75ee8c465eb84057b6924014f14d1f13
institution DOAJ
issn 1932-6203
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-75ee8c465eb84057b6924014f14d1f132025-08-20T03:10:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5437110.1371/journal.pone.0054371Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.Sarah V KedengeBeth P KangwanaEvelyn W WaweruAndrew J NyandigisiJayesh PanditSimon J BrookerRobert W SnowCatherine A Goodman<h4>Background</h4>There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in Kenya, comprising provision of subsidized packs of paediatric ACT to retail outlets, training of retail staff, and community awareness activities. The results demonstrated a substantial increase in ACT availability and coverage, though patient counselling and adherence were suboptimal. We conducted a qualitative study in order to understand why these successes and limitations occurred.<h4>Methodology/principal findings</h4>Eighteen focus group discussions were conducted, 9 with retailers and 9 with caregivers, to document experiences with the intervention. Respondents were positive about intervention components, praising the focused retailer training, affordable pricing, strong promotional activities, dispensing job aids, and consumer friendly packaging, which are likely to have contributed to the positive access and coverage outcomes observed. However, many retailers still did not stock ACT, due to insufficient supplies, lack of capital and staff turnover. Advice to caregivers was poor due to insufficient time, and poor recall of instructions. Adherence by caregivers to dosing guidelines was sub-optimal, because of a wish to save tablets for other episodes, doses being required at night, stopping treatment when the child felt better, and the number and bitter taste of the tablets. Caregivers used a number of strategies to obtain paediatric ACT for older age groups.<h4>Conclusions/significance</h4>This study has highlighted that important components of a successful ACT subsidy intervention are regular retailer training, affordable pricing, a reliable supply chain and community mobilization emphasizing patient adherence and when to seek further care.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054371&type=printable
spellingShingle Sarah V Kedenge
Beth P Kangwana
Evelyn W Waweru
Andrew J Nyandigisi
Jayesh Pandit
Simon J Brooker
Robert W Snow
Catherine A Goodman
Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.
PLoS ONE
title Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.
title_full Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.
title_fullStr Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.
title_full_unstemmed Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.
title_short Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.
title_sort understanding the impact of subsidizing artemisinin based combination therapies acts in the retail sector results from focus group discussions in rural kenya
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0054371&type=printable
work_keys_str_mv AT sarahvkedenge understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya
AT bethpkangwana understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya
AT evelynwwaweru understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya
AT andrewjnyandigisi understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya
AT jayeshpandit understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya
AT simonjbrooker understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya
AT robertwsnow understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya
AT catherineagoodman understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya